- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02929238
Wound Vac Polypropylene Suture Pilot Study
Polypropylene Suture Interfaced Between Wound and Negative Pressure Wound Therapy to Reduce Pain: a Pilot Study
Study Overview
Status
Intervention / Treatment
Detailed Description
If you decide to participate in the study you will be asked to sign this informed consent form prior to beginning any study activities. If you agree to participate the study procedures are as follows:
The participants enrolled in this study will receive NPWT in combination with polypropylene suture being laid out over half of the wound. Enrollment in this study is not considered standard of care.
- You will be randomized (like flipping a coin) to what side of the wound the suture will be placed on. Randomization means the study team has no say in what side the suture goes on. Your information is put into a computer and the computer picks what side to place the suture. The polypropylene suture will be placed over half of your wound. There is an equal chance for the polypropylene suture to be placed on the right or left side. The other half of your wound will not have the polypropylene suture in place and will act as the control (comparison) group in this study. The use of the study polypropylene suture is not considered standard of care.
- The wound vacuum will be placed over the entire wound and will be left in place for no more than 3 days as per standard of care.
- After no more than 3 days at a time during the healing process, the nurses will remove the wound vacuum, dressings, suture, and the sponge.
- One blinded (they are not told which side of the wound the suture is placed on) study physician will come look at your wound. This study physicians will determine if further NPWT, with or without the study polypropylene suture, is needed.
- You will be asked to complete a pain rating questionnaire (rating scale 0-10) in relation to both sides of your wound when the wound vacuum has been removed.
- If further NPWT is needed without the use of the study polypropylene suture, you will be withdrawn from the study
- If discharged with NPWT you will not continue receive polypropylene suture placement and that would be end of study participation
- If further NPWT is needed with the use of negative pressure wound therapy, the polypropylene suture and the sponge will be placed and the process will continue as noted above until your wound is healed or you are withdrawn from the study.
- Information from your medical records will be collected throughout this study. You will also be asked questions about your medical and surgical history as well as what medications you are currently taking.
- Your demographics will be collected including your age, date of birth, race, sex, height, weight, and ethnicity.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
South Carolina
-
Greenville, South Carolina, United States, 29605
- Greenville Health System
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male or female, age 18 years or older
- All patients with an open wound who require NPWT
- Hospitalized patient in need of NPWT for ≥ 6 days
- Willingness to comply with protocol, complete study assessments (pain scale ratings), allow pictures to be taken, and provide written informed consent
Exclusion Criteria:
- Male or female less than 18 years of age
- Prisoners
- Outpatients
- Patients with infected wounds
- Patients with poor blood flow
- Hospitalized patient in need of NPWT for < 6 days
- Not willing to provide written informed consent or remain in compliance with the study protocol requirements
Prisoners will be excluded from this study as they are considered an at risk population.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Polypropylene Suture Right Side
Polypropylene suture will be placed over half the wound.
There is an equal chance for the suture to be placed on the right or left through randomization.
THe other half of the wound will not have the suture placed on it and will act as the control.
The wound vac will be placed over entire wound.
|
Suture Description: The suture used in this study will be a sterilized polypropylene suture and individually crossed in the base of the wound.
Polypropylene is commonly used for commercially available implanted meshes.
The polypropylene suture is intended for single use only and the individual suture will be packaged and purchased sterile.
|
|
Experimental: Polypropylene Suture Left Side
Polypropylene suture will be placed over half the wound.
There is an equal chance for the suture to be placed on the right or left through randomization.
THe other half of the wound will not have the suture placed on it and will act as the control.
The wound vac will be placed over entire wound.
|
Suture Description: The suture used in this study will be a sterilized polypropylene suture and individually crossed in the base of the wound.
Polypropylene is commonly used for commercially available implanted meshes.
The polypropylene suture is intended for single use only and the individual suture will be packaged and purchased sterile.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain Rating Questionnaire
Time Frame: no longer than 6 months
|
testing to see if suture decreases the pain when removing the wound vac
|
no longer than 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blinded Physician Interpretation
Time Frame: no longer than 6 months
|
one blinded physician looks at wound to make sure the suture is not interfering with wound healing
|
no longer than 6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: John Cull, M.D., Prisma Health-Upstate
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- pro00049555
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.